Arrowhead Research | ARWR - PE Price to Earnings


Arrowhead Research reported 41.67 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Agios Pharmaceuticals USD 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
Incyte USD 14.84 2.79 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Ligand Pharmaceuticals USD 60.65 17.62 Sep/2025
Merck USD 13.92 5.08 Dec/2025
Moderna USD 27.22 14.51 Jun/2023
Novartis USD 15.74 0.15 Sep/2025
Sarepta Therapeutics USD 27.27 0 Sep/2025
TG Therapeutics USD 10.76 2.32 Dec/2025
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025
Xencor USD 29.92 3.22 Sep/2022